Related Experiment Video

Updated: Jul 24, 2026

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge
09:32

Continuous Venous-Arterial Doppler Ultrasound During a Preload Challenge

Published on: January 20, 2023

Doppler-derived dP/dt and -dP/dt predict survival in congestive heart failure

T J Kolias1, K D Aaronson, W F Armstrong

  • 1Division of Cardiology, University of Michigan Medical Center, Ann Arbor 48109-0273, USA. tkolias@umich.edu

Journal of the American College of Cardiology
|November 18, 2000
PubMed

Insights

Novel Doppler indices accurately predict survival in patients with congestive heart failure (CHF). These new measurements, including dP/dt and -dP/dt, offer improved prognostic capabilities for CHF patients.

Area of Science:

  • Cardiology
  • Echocardiography
  • Medical Technology

Background:

  • Congestive heart failure (CHF) carries a high risk of mortality and cardiac transplantation.
  • Current methods for predicting survival in CHF patients are limited.

Purpose of the Study:

  • To assess novel Doppler indices for predicting survival in patients diagnosed with congestive heart failure (CHF).
  • To evaluate the efficacy of left ventricular (LV) systolic and diastolic function Doppler indices in prognostication.

Main Methods:

  • Prospective determination of Doppler-derived dP/dt and -dP/dt from mitral regurgitation jets in 56 chronic CHF patients.
  • Collection of baseline clinical and echocardiographic data, followed by clinical follow-up.

Main Results:

  • Doppler-derived dP/dt and -dP/dt significantly predicted event-free survival.
  • Combined Doppler-derived risk groups demonstrated strong predictive value for patient outcomes (p = 0.0001).
  • Multivariable analysis identified Doppler risk groups, inotrope requirement, and BUN as independent predictors.

Conclusions:

  • New Doppler indices, specifically dP/dt and -dP/dt, effectively predict event-free survival in CHF patients.
  • Risk stratification using combined Doppler indices improves prognostic accuracy for congestive heart failure.
Abstract

More Related Videos

A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models07:49

A Pacing-Controlled Procedure for the Assessment of Heart Rate-Dependent Diastolic Functions in Murine Heart Failure Models

Published on: July 21, 2023

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease08:57

Pulsed Wave Doppler Assessment of Diastolic Dysfunction in the ZSF-1 Rat Model of Pulmonary Hypertension Due to Left Heart Disease

Published on: May 22, 2026

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send blood...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...